Centogene NV (CNTG) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Centogene N.V., a biotech company, has been granted an extension until August 26, 2024, to meet Nasdaq’s minimum Market Value of Publicly Held Shares requirement and avoid delisting. The company is actively working on a strategic review process, which includes a potential sale, to comply with the listing standards. However, the possibility of achieving these milestones and maintaining its Nasdaq listing remains uncertain.
For further insights into CNTG stock, check out TipRanks’ Stock Analysis page.
